We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for tebentafusp (Adjutor Healthcare Pty Ltd)
Active ingredients
tebentafusp
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
concentrated solution for infusion
Indication
For the treatment of uveal melanoma
Therapeutic area
Oncology